Non-radiographic spondyloarthritis: A theoretical concept or a real entity?

Joint Bone Spine

Volumn 79, Issue 6, 2012, Pages 531-533

  Wendling, Daniel ^a,b   Prati, Clément ^a   Claudepierre, Pascal ^c   Guillot, Xavier ^a   Breban, Maxime ^d,e  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b EA 4266 Université de Franche Comté ^*  (France)

^c HENRI MONDOR HOSPITAL   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^e INSTITUT COCHIN   (France)

Author keywords

Criteria; Diagnosis; Imaging; Spondylarthritis; TNF antagonists; Treatment

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; PLACEBO; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANKYLOSING SPONDYLITIS; ARTHRITIS; EARLY DIAGNOSIS; EDITORIAL; FOLLOW UP; HUMAN; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; SACROILIITIS; SPONDYLARTHRITIS; TREATMENT DURATION;

HUMANS; MAGNETIC RESONANCE IMAGING; SACROILIAC JOINT; SACROILIITIS; SPONDYLARTHRITIS;

EID: 84870658837     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2012.06.009     Document Type: Editorial

References (20)

1. Claudepierre P., Wendling D., Breban M., et al. Ankylosing spondylitis, spondyloarthropathy, spondyloarthritis, or spondyloarthritis: what's in a name?. Joint Bone Spine 2012, 10.1016/j.jbspin.2012.06.003.
2. Wendling D., Toussirot E., Streit G., et al. Imaging study scores for ankylosing spondylitis. Joint Bone Spine 2006, 73:655-660.
3. Chary-Valckenaere I., d'Agostino M.A., Loeuille D. Role for imaging studies in ankylosing spondylitis. Joint Bone Spine 2011, 78:138-143.
4. Wendling D., Prati C., Toussirot E., et al. Spondyloarthritis, spondyloarthritides: diagnosis and classification criteria. Rev Rhum Monographies 2010, 77:43-47.
5. Rudwaleit M., Khan M.A., Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria?. Arthritis Rheum 2005, 52:1000-1008.
6. Wendling D. Ankylosing spondylitis without radiological sacroiliitis: a (re)current problem. Joint Bone Spine 2006, 73:584-586.
7. Rudwaleit M., van der Heijde D., Landewé R., et al. The development of assessment of spondyloarthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009, 68:777-783.
8. Rudwaleit M., van der Heijde D., Landewé R., et al. The assessment of spondyloarthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011, 70:25-31.
9. Bennett A.N., McGonagle D., O'Connor P., et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at 8 years. Arthritis Rheum 2008, 58:3413-3418.
10. Aydin S.Z., Maksymowych W.P., Bennett A.N., et al. Validation of the ASAS criteria and definition of a positive MRI of the sacroiliac joint in an inception cohort of axial spondyloarthritis followed up for 8 years. Ann Rheum Dis 2012, 71:56-60.
11. Poddubnyy D., Rudwaleit M., Haibel H., et al. Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis 2011, 70:1369-1374.
12. Rudwaleit M., Jurik A.G., Hermann K.G., et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 2009, 68:1520-1527.
13. Weber U., Lambert R.G., Østergaard M., et al. The diagnostic utility of magnetic resonance imaging in spondyloarthritis: an international multicenter evaluation of 187 subjects. Arthritis Rheum 2010, 62:3048-3058.
14. Dougados M., d'Agostino M.A., Benessiano J., et al. The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients. Joint Bone Spine 2011, 78:598-603.
15. Poddubnyy D.A., Rudwaleit M., Listing J., et al. Comparison of a high-sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis. Ann Rheum Dis 2010, 69:1338-1341.
16. Rudwaleit M., Haibel H., Baraliakos X., et al. The early disease stage in axial spondylarthritis: results from the German spondyloarthritis inception cohort. Arthritis Rheum 2009, 60:717-727.
17. Haibel H., Rudwaleit M., Listing J., et al. Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a 12-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week 52. Arthritis Rheum 2008, 58:1981-1991.
18. Barkham N., Keen H.I., Coates L.C., et al. Clinical and imaging efficacy of infliximab in HLA-B27-positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum 2009, 60:946-954.
19. Song I.H., Hermann K., Haibel H., et al. Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial. Ann Rheum Dis 2011, 70:590-596.
20. Sieper J., van der Heijde D., Dougados M., et al. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis. Results from a phase 3 study. Arthritis Rheum 2011, 63:2486A.